Serena Williams, one of the most successful athletes of all time, has spoken out about using weight loss drugs - she says, to ...

Demand for Novo Nordisk A/S’s weight-loss blockbuster Wegovy is getting a boost in the UK from an unexpected corner: ...

With results from highly anticipated trials of Eli Lilly’s orforglipron and Viking Therapeutics’ VK2735 “underwhelming” ...

This week on "The Readout LOUD," we discuss Viking Therapeutics' obesity flop and dish on the growing "pharm to table" ...

Lil Terrio has given fans a major life update and advice on how to push through adversity. On Thursday, the 17-year-old ...

A new European obesity framework adds waist-to-height ratio and comorbidities to BMI assessment. Could this help identify ...

The company is the latest facing historic losses as pharmaceutical firms compete to develop a weight-loss pill.

Lilly will receive exclusive rights to develop and commercialize drug candidates discovered using Superluminal's AI-driven ...

A new study has created the first single-cell map of how DNA is regulated and organized inside different cell-types of human ...

Viking Therapeutics’ VK2735 achieves a 10.9% placebo-adjusted weight loss at 13 weeks, but a less than ideal safety profile ...

U.S. prices for obesity-treatment pills that Eli Lilly and Novo Nordisk aim to launch next year likely will be on par with ...

Obesity before pregnancy, not just during, may shape a child’s brain and raise the risk of autism spectrum disorder, a new ...